Product Description: Veligrotug is an IgG1-kappa, anti-IGF1R (insulin-like growth factor 1 receptor, CD221) chimeric monoclonal antibody[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.
CAS Number: 2728655-31-8
Molecular Weight: N/A
Compound Purity: 99.25
Research Area: Cancer
Solubility: H2O
Target: IGF-1R